STOCK TITAN

PowerUp Acquisition Corp. - $PWUP STOCK NEWS

Welcome to our dedicated page for PowerUp Acquisition news (Ticker: $PWUP), a resource for investors and traders seeking the latest updates and insights on PowerUp Acquisition stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PowerUp Acquisition's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PowerUp Acquisition's position in the market.

Rhea-AI Summary
PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. have announced the filing of a registration statement with the SEC for a proposed business combination. The closing of the transaction is subject to approval by PowerUp's shareholders, satisfaction of conditions in the definitive agreement, and other customary closing conditions. Upon closing, Visiox will become a wholly-owned subsidiary of Visiox Holdings, with their stock and warrants expected to be listed on Nasdaq under the symbols 'VSXP' and 'VSXPW'.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
-
Rhea-AI Summary
Visiox Pharmaceuticals, Inc. (Nasdaq: VSXP) and PowerUp Acquisition Corp. (Nasdaq: PWUP) have announced a definitive agreement for a business combination that will result in Visiox becoming a publicly traded company on the Nasdaq Capital Market. The business combination is expected to close in the first quarter of 2024, and upon closing, the combined company will be named Visiox Holdings, Inc. with its common stock and warrants expected to be listed on Nasdaq under the ticker symbols VSXP and VSXPW, respectively. Visiox's pipeline includes treatments for ocular hypertension, open angle glaucoma, and post-surgical inflammation and pain, addressing highly prevalent disease states in need of new treatment options. The company's CEO, Ryan Bleeks, expressed anticipation that the funds from this transaction will help accelerate the commercialization of key drug candidates.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.89%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
PowerUp Acquisition Corp.

Nasdaq:PWUP

PWUP Rankings

PWUP Stock Data

100.97M
1.80M
79.94%
23.51%
0.02%
Shell Companies
Financial Services
Link
United States of America
NEW YORK